Novartis Considers Appealing $1.5 Million Whistleblower Verdict

Drug Industry Daily
A A
Novartis is hinting that it will appeal a New Jersey jury’s verdict awarding $1.5 million to a former executive who alleged that the company created a bogus drug study to disguise kickbacks to a leading drug distributor.

To View This Article:

Login

Subscribe To Drug Industry Daily